[Platelet inhibition and activation. Mechanisms and clinical implications.]

Alberio, L; Clemetson, KJ (2005). [Platelet inhibition and activation. Mechanisms and clinical implications.]. Herz, 30(3), pp. 176-80. München: Urban & Vogel 10.1007/s00059-005-2681-x

[img]
Preview
Text
059_2005_Article_2681.pdf - Published Version
Available under License Publisher holds Copyright.

Download (244kB) | Preview

The sensitivity to activation of platelets is part of the delicate equilibrium differentiating hemostasis from thrombosis. Under physiological conditions it is maintained by downregulating platelet activity and removing agonists. Under pathologic conditions the clinician tries to restore this equilibrium with pharmaceutical drugs. The results obtained by such treatments are steadily improving but there is still need for better knowledge of the mechanisms involved and for alternative inhibitors.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Theodor Kocher Institute

UniBE Contributor:

Clemetson, Kenneth John

ISSN:

0340-9937

ISBN:

15902367

Publisher:

Urban & Vogel

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:52

Last Modified:

21 Nov 2019 03:20

Publisher DOI:

10.1007/s00059-005-2681-x

PubMed ID:

15902367

Web of Science ID:

000229764000003

BORIS DOI:

10.7892/boris.22157

URI:

https://boris.unibe.ch/id/eprint/22157 (FactScience: 32148)

Actions (login required)

Edit item Edit item
Provide Feedback